Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Clinical trial NCT00668200 · COMPLETED
Trial details
- NCT number
- NCT00668200
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2012-11-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.